Understanding Alpha-1 With The National Jewish Medical and Research Center

Alpha-1 isn’t a rare disease, just rarely diagnosed

Lifetime Television’s “The Balancing Act” welcomes Dr. Robert Sandhaus from the National Jewish Medical and Research Center as he talks about Alpha-1 (Antitrypsin Deficiency), explaining why this disease is so often misdiagnosed.  Alpha-1 Testing is now more readily available; thanks to CSL Behring’s wider range of testing resources.


The Balancing Act


Behind the Mystery: Alpha –1

With symptoms similar to COPD, Alpha-1 isn’t a rare disease, just rarely diagnosed.

Are you or someone you know showing signs of chronic respiratory problems?

Diagnosed with COPD? Asthma? Emphysema? Alpha-1 may be the underlying cause of your chronic respiratory symptoms.
Symptoms of Alpha-1 include:

  • Shortness of breath
  • Wheezing or non-responsive asthma
  • Coughing with or without phlegm
  • Recurring respiratory infections
  • Rapid deterioration of lung function
  • Unexplained liver problems and /or elevated liver enzymes

Alpha-1, commonly misdiagnosed as Asthma, COPD and/or Emphysema, on average takes up to 7 years and 3 different physicians before an accurate diagnosis can be made. Talk with your doctor about getting tested for Alpha-1.

Alpha –1, or Antitrypsin Deficiency, is a genetic condition that is passed on by parents to their children through their genes and can cause serious liver disease in children and liver and/or lung disease in adults. It affects 1 out of every 2500 people.

A simple blood test can make all the difference in properly diagnosing this disorder. Alpha-1 testing is made easy by CSL Behring, providing a range of testing resources available for physicians, at no charge to the patient.

CSL Behring’s tagline is “Biotherapies for Life”. They research, develop, manufacture and market biotherapies to treat rare, often life-threatening conditions. Offering a wide range of testing resources, their customers rely on our therapies to help them live better and, in many cases, longer lives.

Make sure to tune in to The Balancing Act on Tuesday, November 5th and 12th at 7:00 am (ET/PT) as Dr. Robert Sandhaus, Director of the Alpha-1 Program at the National Jewish Health Center in Denver, CO talks about why Alpha-1 is so misdiagnosed. A woman who has Alpha-1 will also share her story of diagnosis and managing the disease.

http://www.cslbehring-us.com/


The Balancing Act® airing on Lifetime TV Goes Behind the Mystery of Alpha-1

FOR IMMEDIATE RELEASE

Media Contact:
O2 Media, Inc.
pamela@o2mediainc.com
(954) 691-1102

The Balancing Act® airing on Lifetime TV Talks Internet Threat Intervention; Goes Behind the Mystery of Alpha-1

McAfee, Inc. and CSL Behring LLC Take Center Stage on November 5th Show

(Pompano Beach, FL – PR.Com/CISION – November 1, 2013) Popular morning show The Balancing Act® airing on Lifetime® TV welcomes McAfee Inc., a trusted name in securing digital life, and CSL Behring, a company that manufacturer biotherapies to treat rare conditions, to the show airing on Tuesday, November 5th at 7:00 a.m. (ET/PT). CSL Behring is part of the “Behind the Mystery: Rare and Genetic Diseases“ programming. Make sure to tune in as The Balancing Act hosts help jump start the day with animated conversation and trusted information to empower a woman’s life.

Don’t miss these featured segments taking center stage on The Balancing Act®:

– Go Behind the Mystery of Alpha-1 with CSL Behring
Learn about a lung disease known as “Alpha-1” that is commonly misdiagnosed as COPD, asthma or/and emphysema and often takes up to 7 years and multiple physicians to accurately diagnose. Join Dr. Robert Sandhaus, Director of the Alpha-1 Program at the National Jewish Health Center in Denver, as he talks about Alpha-1 (Antitrypsin Deficiency), explaining why this disease is so often misdiagnosed, and a simple way to test for it; along with a patient who shares her story. Alpha-1 Testing is now more readily available as CSL Behring offers advanced testing resources. http://www.cslbehring-us.com/

“The Balancing Act provided us with a unique opportunity to reach viewers who may be diagnosed, or may know someone who is diagnosed with COPD, Emphysema, or Asthma. This program has allowed us to increase our efforts on making Alpha-1 more publicly known.”

– Keep Hackers at Bay with McAfee
How do you keep your family safe from hackers, malicious viruses and other Internet threats? Stacey Conner of McAfee, shares the latest when it comes to protecting your digital devices; how to keep your family safer from hackers, malicious viruses and other common and not- so-common Internet threats. http://www.LiveSafe.com
About The Balancing Act® on Lifetime Television
Now in its 6th year, The Balancing Act® continues to empower women in all aspects of their lives. The mission at The Balancing Act is simple – the show strives to help today’s modern woman balance it all by bringing them exceptional solutions to everyday problems. Entertaining, educational and trusted by women, viewers can tune in to America’s premier morning show The Balancing Act on weekday mornings at 7:00 am (ET/PT) on Lifetime television.

For additional information or to view a segment visit: http://www.thebalancingact.com
Join the Conversation!
Like us on Facebook at: https://www.facebook.com/TheBalancingActFans
Follow us on Twitter at: http://twitter.com/#!/balancingacttv
Watch us on YouTube at: http://www.youtube.com/thebalancingact